Bioengineering ethics for the age of microphysiological systems
Open Access
- 20 March 2025
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 13, 1497060
Abstract
The development of microphysiological systems (MPS) is pushing ethical standards in biomedical research to a breaking point. This article argues that only a perspective drawing from engineering ethics will be able to address the new challenges raised by organoids and organs-on-chips. Extending progressively the scope of moral questioning, we discuss successively the following areas: i) individual consent: when cell lines are generated and human biomaterial is circulated and incorporated into biotechnologies whose life cycle will far exceed the scope envisioned by donors and manufacturers, the classic notion of informed consent becomes almost obsolete, or at least needs to be revisited. ii) Collective deliberation: MPSs raise many expectations for animal replacement and the advancement of precision and regenerative medicine. The management of these prospects by different stakeholders, and for everyone, is itself an ethical challenge at the interface of science and society. iii) Consideration of novel entities: some complex microphysiological systems may be endowed with a moral status in the near future, and this will have an impact on how researchers treat them and work with them.Keywords
This publication has 13 references indexed in Scilit:
- Dynamic governance: A new era for consent for stem cell researchStem Cell Reports, 2024
- Towards in vitro models for reducing or replacing the use of animals in drug testingNature Biomedical Engineering, 2023
- An ethical framework for human embryology with embryo modelsCell, 2023
- Global Literature Analysis of Organoid and Organ‐on‐Chip ResearchAdvanced Healthcare Materials, 2023
- Public perceptions and expectations: Disentangling the hope and hype of organoid researchStem Cell Reports, 2023
- Promises and challenges of organoid-guided precision medicineMed, 2021
- Organoids for replacement therapy: expectations, limitations and realityCurrent Opinion in Organ Transplantation, 2019
- Organoids as hybrids: ethical implications for the exchange of human tissuesJournal of Medical Ethics, 2018
- Individualized medicine using intestinal responses to CFTR potentiators and correctorsPediatric Pulmonology, 2016
- Bioethics and the Future of Stem Cell Research2013